Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Change in Cash (2022 - 2025)

Historic Change in Cash for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to -$17.4 million.

  • Gossamer Bio's Change in Cash rose 7025.32% to -$17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.5 million, marking a year-over-year increase of 6392.83%. This contributed to the annual value of $14.0 million for FY2024, which is 11748.6% up from last year.
  • According to the latest figures from Q3 2025, Gossamer Bio's Change in Cash is -$17.4 million, which was up 7025.32% from -$2.7 million recorded in Q2 2025.
  • Over the past 5 years, Gossamer Bio's Change in Cash peaked at $59.2 million during Q3 2022, and registered a low of -$58.4 million during Q3 2024.
  • Its 4-year average for Change in Cash is -$11.6 million, with a median of -$17.4 million in 2025.
  • Its Change in Cash has fluctuated over the past 5 years, first soared by 27003.33% in 2024, then crashed by 35248.74% in 2025.
  • Over the past 4 years, Gossamer Bio's Change in Cash (Quarter) stood at -$41.5 million in 2022, then fell by 21.68% to -$50.5 million in 2023, then surged by 134.87% to $17.6 million in 2024, then tumbled by 198.67% to -$17.4 million in 2025.
  • Its last three reported values are -$17.4 million in Q3 2025, -$2.7 million for Q2 2025, and -$17.1 million during Q1 2025.